Physician
Harold Zilberman MD Chartered
Harold Zilberman MD Chartered was paid $14.28M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 20% of everything it billed.
33Billing provider infoHAROLD ZILBERMAN MD CHARTERED
LAS VEGAS, NV 89109
LAS VEGAS, NV 89109
33aNPI1942364054assigned 12/21/2006
33bProvider typePediatrics Physician
28Total paid$14.28M
24GClaims459,217
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#2 of 267
Median peer was paid$116K
This provider vs. median123×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,061 | $94K | |
| 2019 | 78,532 | $2.50M | |
| 2020 | 72,189 | $2.20M | |
| 2021 | 79,618 | $2.39M | |
| 2022 | 76,413 | $2.50M | |
| 2023 | 83,868 | $2.57M | |
| 2024incomplete | 66,536 | $2.02M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 50,533 | 47,234 | $2.90M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 18% | 49,347 | 47,345 | $2.59M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 29,999 | 28,394 | $2.58M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 19,896 | 17,947 | $1.63M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 18,198 | 17,715 | $1.59M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.3% | 11,925 | 11,604 | $1.04M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.4% | 5,028 | 4,890 | $481K |
| 99058 | 3.0% | 24,551 | 23,115 | $424K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.1% | 3,948 | 3,707 | $296K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,058 | 4,882 | $95K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,611 | 7,337 | $62K |
| 90461 | <1% | 2,951 | 2,885 | $61K |
55 more codes
| 99383 | <1% | 629 | $56K | |
| 94010 | <1% | 1,752 | $49K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,520 | $48K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 6,644 | $42K |
| 83655 | <1% | 5,226 | $41K | |
| 92567 | <1% | 3,406 | $37K | |
| 36416 | <1% | 12,518 | $33K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 692 | $31K |
| 99460 | <1% | 374 | $30K | |
| 96127 | <1% | 5,993 | $26K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 379 | $23K |
| 99384 | <1% | 189 | $19K | |
| 99381 | <1% | 203 | $17K | |
| 99382 | <1% | 149 | $13K | |
| 92587 | <1% | 33,881 | $12K | |
| 85018 | <1% | 8,008 | $12K | |
| 93000 | <1% | 828 | $12K | |
| 99188 | <1% | 909 | $11K | |
| 92015 | Determination of refractive state | <1% | 28,245 | $10K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 57 | $5K |
| 0012A | <1% | 154 | $3K | |
| 87807 | <1% | 292 | $2K | |
| 0011A | <1% | 159 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $2K |
| 99463 | <1% | 14 | $1K | |
| 94667 | <1% | 34 | $616.14 | |
| 69210 | <1% | 27 | $428.72 | |
| 81002 | <1% | 153 | $283.85 | |
| 90671 | <1% | 4,044 | $221.58 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $196.68 |
| 99177 | <1% | 1,248 | $188.85 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 14 | $154.14 |
| 90670 | <1% | 9,666 | $96.14 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 34 | $49.90 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 47 | $46.48 |
| 90686 | <1% | 16,653 | $33.52 | |
| 90713 | <1% | 14,271 | $22.26 | |
| 90707 | <1% | 5,663 | $19.27 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 47 | $9.08 |
| 94760 | <1% | 21 | $5.80 | |
| 90685 | <1% | 1,645 | $1.70 | |
| 90680 | <1% | 8,214 | $1.04 | |
| 90651 | <1% | 2,533 | $1.04 | |
| 90744 | 0% | 6,785 | $0.00 | |
| 90716 | 0% | 5,695 | $0.00 | |
| 90619 | 0% | 626 | $0.00 | |
| 91301 | 0% | 285 | $0.00 | |
| 90656 | 0% | 867 | $0.00 | |
| 99000 | 0% | 61 | $0.00 | |
| 90648 | 0% | 13,751 | $0.00 | |
| 90700 | 0% | 17,644 | $0.00 | |
| 90633 | 0% | 6,537 | $0.00 | |
| 90734 | 0% | 859 | $0.00 | |
| 90715 | 0% | 489 | $0.00 | |
| 90710 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZILBERMAN, HAROLD (OWNER)